Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

1.8K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive neurological decline in a measles survivor: A case report of subacute sclerosing panencephalitis in Zambia.

IDCases·2026
Same author

New-onset refractory status epilepticus/febrile infection-related epilepsy syndrome centers of excellence: A framework for coordinated care, research, and improved outcomes.

Epilepsia·2026
Same author

International consensus recommendations for the diagnosis and treatment of Rasmussen syndrome: A modified Delphi procedure.

Epilepsia·2026
Same author

Powassan Virus Encephalitis in Pediatric Patients.

Journal of child neurology·2025
Same author

Assessment of Seizure Action Plans in Pediatric Convulsive Status Epilepticus: Focus on Benzodiazepine-Responsive and Resistant Cases.

Neurology. Clinical practice·2025
Same author

New onset refractory status epilepticus: Long-term outcomes beyond seizures.

Epilepsia·2025

Related Experiment Video

Updated: Feb 25, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.7K

Update on pediatric autoimmune encephalitis-associated epilepsy.

Celia Greenlaw1, Coral M Stredny1,2

  • 1Center in Neuroimmunology.

Current Opinion in Neurology
|February 24, 2026
PubMed
Summary

Autoimmune encephalitis-associated epilepsy (AEAE) in children often leads to drug-resistant seizures and cognitive decline. Early diagnosis and targeted immunotherapies are crucial for improving long-term outcomes in pediatric AEAE.

Keywords:
acute symptomatic seizuresautoimmune encephalitisautoimmune encephalitis-associated epilepsyimmunotherapy

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.2K
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.9K

Related Experiment Videos

Last Updated: Feb 25, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.7K
Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.2K
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.9K

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Autoimmune encephalitis-associated epilepsy (AEAE) originates from immune system dysfunction, leading to persistent seizures due to structural brain damage.
  • Chronic, often drug-resistant epilepsy is a common consequence in pediatric patients.
  • Early intervention with immunomodulation holds potential for better long-term prognoses.

Purpose of the Study:

  • To review current understanding of diagnosis, treatment, and long-term outcomes for pediatric AEAE.
  • To highlight advances in recognizing immune system roles in epilepsy.
  • To summarize emerging diagnostic and therapeutic strategies.

Main Methods:

  • Review of current literature on pediatric AEAE.
  • Analysis of diagnostic advancements, including predictive scores and biomarkers.
  • Evaluation of treatment strategies and their impact on outcomes.

Main Results:

  • Enhanced understanding of immune dysfunction in epilepsy has driven diagnostic and treatment progress.
  • Emerging biomarkers (EEG, neurofilament light chain, cytokines) aid diagnosis and prognostication.
  • Children face higher risks for AEAE, but predicting epilepsy risk remains difficult; long-term outcomes are frequently poor, marked by refractory seizures and cognitive decline.

Conclusions:

  • Pediatric AEAE significantly impacts patient morbidity.
  • Ongoing research focuses on identifying risk factors, biomarkers, and targeted therapies to enhance outcomes for children with AEAE.